<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 21 Mar 2021 19:22:58 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>开拓药业的新出路：市值较年前翻3倍</title><link>https://mp.weixin.qq.com/s/jVqZjmlNbs-iLwGXxaG9Zg</link><description></description><content:encoded><![CDATA[开拓药业的新出路：市值较年前翻3倍]]></content:encoded><pubDate>Sun, 21 Mar 2021 19:00:15 +0800</pubDate></item><item><title>近4000亿市值！药明生物连续并购生物药CDMO工厂，产能欲突破30万升</title><link>https://mp.weixin.qq.com/s/AOi2h5fbsLYBrzaZUL_CsQ</link><description></description><content:encoded><![CDATA[近4000亿市值！药明生物连续并购生物药CDMO工厂，产能欲突破30万升]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>嘉和生物CD20xCD3双抗提交澳大利亚临床申请</title><link>https://mp.weixin.qq.com/s/kpFnHpC-sPeAuoam6ybhmg</link><description></description><content:encoded><![CDATA[嘉和生物CD20xCD3双抗提交澳大利亚临床申请]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>白云山分拆广州医药到港股主板上市获得受理！</title><link>https://mp.weixin.qq.com/s/ppPR46CAc_VyWFtcwlcI4Q</link><description></description><content:encoded><![CDATA[白云山分拆广州医药到港股主板上市获得受理！]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>贝达药业引进的EGFR/c-Met双抗获批临床</title><link>https://mp.weixin.qq.com/s/AbZjgRFlwlsZSYpa5g_N0w</link><description></description><content:encoded><![CDATA[贝达药业引进的EGFR/c-Met双抗获批临床]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>又有6款创新药拟纳入突破性治疗药物程序！</title><link>https://mp.weixin.qq.com/s/8l56EU4UE8BSLIu4CchwUQ</link><description></description><content:encoded><![CDATA[又有6款创新药拟纳入突破性治疗药物程序！]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>这3款新药拟获得优先审评审批资格！</title><link>https://mp.weixin.qq.com/s/yv9ntR0hBonZMY1hiEB37g</link><description></description><content:encoded><![CDATA[这3款新药拟获得优先审评审批资格！]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>药明生物宣布收购辉瑞中国生物药原液和制剂生产基地</title><link>https://mp.weixin.qq.com/s/3SXsVLlNWtck-7zeiTIwww</link><description></description><content:encoded><![CDATA[药明生物宣布收购辉瑞中国生物药原液和制剂生产基地]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>蒋华良院士|阿尔脉生物牵手再鼎医药，人工智能结合DNA编码开发创新药</title><link>https://mp.weixin.qq.com/s/eJdpHwv0a5wR6I9udCZuMA</link><description></description><content:encoded><![CDATA[蒋华良院士|阿尔脉生物牵手再鼎医药，人工智能结合DNA编码开发创新药]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:05:37 +0800</pubDate></item><item><title>纳米抗体平台|洛启生物完成亿元人民币A轮融资</title><link>https://mp.weixin.qq.com/s/yuufM6wQOyzJYWd-lC-g1g</link><description></description><content:encoded><![CDATA[纳米抗体平台|洛启生物完成亿元人民币A轮融资]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:05:37 +0800</pubDate></item><item><title>三家biotech同一天宣布巨额融资超10亿美元！</title><link>https://mp.weixin.qq.com/s/Gku8nVeUQwDyS6-vHXrvNw</link><description></description><content:encoded><![CDATA[三家biotech同一天宣布巨额融资超10亿美元！]]></content:encoded><pubDate>Tue, 16 Mar 2021 17:05:37 +0800</pubDate></item><item><title>从前讲仿制药低水平重复，现如今可能是新药高频率重复</title><link>https://mp.weixin.qq.com/s/C_NzvcvcgSqf10b4-eQo6Q</link><description></description><content:encoded><![CDATA[从前讲仿制药低水平重复，现如今可能是新药高频率重复]]></content:encoded><pubDate>Sat, 13 Mar 2021 18:24:29 +0800</pubDate></item><item><title>【倡议长期主义】中国式biotech大都抵不过亏损</title><link>https://mp.weixin.qq.com/s/Sb2EBzA9vmC84N_xr61_8Q</link><description></description><content:encoded><![CDATA[【倡议长期主义】中国式biotech大都抵不过亏损]]></content:encoded><pubDate>Sat, 13 Mar 2021 18:06:14 +0800</pubDate></item><item><title>烨辉医药​宣布与Ardeagen进行战略合作，共同开发多达3款ADC药物</title><link>https://mp.weixin.qq.com/s/Cx4Vj6b-foezObFdeAlKkg</link><description></description><content:encoded><![CDATA[烨辉医药​宣布与Ardeagen进行战略合作，共同开发多达3款ADC药物]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>应世生物与诗健生物宣布签订创新抗体药物研发战略合作协议</title><link>https://mp.weixin.qq.com/s/rPOJZxF9oLpWc7Gj6Ha1lA</link><description></description><content:encoded><![CDATA[应世生物与诗健生物宣布签订创新抗体药物研发战略合作协议]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>石药集团1.7亿元引进康诺亚一款IL-4Rα抗体中国大陆部分适应症权益</title><link>https://mp.weixin.qq.com/s/14OMKeKjPDNViyohXlmO1g</link><description></description><content:encoded><![CDATA[石药集团1.7亿元引进康诺亚一款IL-4Rα抗体中国大陆部分适应症权益]]></content:encoded><pubDate>Thu, 11 Mar 2021 17:25:33 +0800</pubDate></item><item><title>三代EGFR竞争来袭！石药2亿元引进一款！</title><link>https://mp.weixin.qq.com/s/eb-cXhAwkDMoBwWDV0pI4w</link><description></description><content:encoded><![CDATA[三代EGFR竞争来袭！石药2亿元引进一款！]]></content:encoded><pubDate>Wed, 10 Mar 2021 13:53:34 +0800</pubDate></item><item><title>估值超18亿元！高瓴押注这家CRO公司提交上市申请，尤启冬担任独立董事！</title><link>https://mp.weixin.qq.com/s/SA_HbgT54Cr8idHJJTt8vg</link><description></description><content:encoded><![CDATA[估值超18亿元！高瓴押注这家CRO公司提交上市申请，尤启冬担任独立董事！]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:18:22 +0800</pubDate></item><item><title>估值超8亿美元，依生生物提交港股IPO申请！</title><link>https://mp.weixin.qq.com/s/gcM37fmTIu0ktNlb3ysErQ</link><description></description><content:encoded><![CDATA[估值超8亿美元，依生生物提交港股IPO申请！]]></content:encoded><pubDate>Tue, 09 Mar 2021 13:18:22 +0800</pubDate></item><item><title>超1.13亿元！通化东宝牵手药明康德，强势进军创新药领域</title><link>https://mp.weixin.qq.com/s/LCX8wVTx-TVk-kgy2XzCww</link><description></description><content:encoded><![CDATA[超1.13亿元！通化东宝牵手药明康德，强势进军创新药领域]]></content:encoded><pubDate>Mon, 08 Mar 2021 10:11:44 +0800</pubDate></item></channel></rss>